OSI Systems, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a OSIS research report →
Range $265 – $274
Price Chart
About the company
OSI Systems, Inc. (OSIS) is a global company specializing in the design and production of advanced electronic systems and components. Its operations are structured across three distinct business segments: Security, Healthcare, and Optoelectronics and Manufacturing.
- CEO
- Ajay Mehra
- IPO
- 1997
- Employees
- 7,806
- HQ
- Hawthorne, CA, US
Get TickerSpark's AI analysis on OSIS
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $2.94B
- P/E
- 20.59
- Fwd P/E
- 16.32
- PEG
- 3.02
- P/S
- 1.72
- P/B
- 4.00
- EV/EBITDA
- 14.99
- Div Yield
- 0.00%
- Gross Margin
- 32.90%
- Op Margin
- 12.16%
- Net Margin
- 8.79%
- ROE
- 18.92%
- ROIC
- 9.09%
Latest fiscal year · YoY change
- Revenue
- $1.79B+4.3%
- Gross Profit
- $593.09M+1.0%
- Op Income
- $218.97M
- Net Income
- $154.71M+3.4%
- EPS
- $8.95+0.4%
- OCF Growth
- +182.7%
- FCF Growth
- +337.4%
- 52W High
- $311.72
- 52W Low
- $186.35
- 50D MA
- $197.38
- 200D MA
- $232.33
- Beta
- 1.26
- RSI (14)
- 41
- Avg Volume
- 244.36K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
OSI Systems delivered record first-quarter revenue, EPS, bookings, and backlog, and raised full-year EPS guidance while keeping revenue guidance unchanged.· October 29, 2026
- Q1 revenue was a record $403 million, up 5% year over year, and adjusted EPS was a record $1.66, up 17%.
- Backlog hit a record $2.1 billion and book-to-bill was 1.4, signaling strong demand and second-half visibility.
- Security revenue rose 4% with strong bookings, including new CBP IDIQ contracts and $90 million of RF bookings; Opto revenue rose 9%, while Healthcare revenue fell 14%.
- Management reaffirmed fiscal 2027 revenue guidance of $1.875 billion to $1.930 billion but raised non-GAAP EPS guidance to $11.28 to $11.64.
- Free cash flow was about $30 million in Q1, operating cash flow was $37 million, and the company repurchased about 306,000 shares for approximately $62 million.
First-quarter fiscal 2027 revenue was $403 million, up 5% year over year, a Q1 record. Adjusted EPS was $1.66, up 17% year over year, also a Q1 record. Gross margin was 30.7% versus 32.0% a year ago, and adjusted operating margin was 9.5% versus 10.3% last year. Operating cash flow was $37 million versus $17 million, and free cash flow was approximately $30 million, about 120% of GAAP net income. Revenue by division: Security $264 million, up 4%; Opto $120 million, up 9% including intercompany sales and up 16% to third-party customers; Healthcare down 14%. Management raised fiscal 2027 non-GAAP EPS guidance to $11.28 to $11.64 from prior guidance, while reaffirming revenue guidance of $1.875 billion to $1.930 billion. They expect Q2 revenue to be modestly down year over year because of the tougher Middle East comparison and the Mexico program impact, then stronger growth in the second half. They continue to expect free cash flow to exceed net income for the full year.
Ajay Mehra said the quarter largely unfolded as expected, with strong bookings, record backlog, and a path to a stronger second half of fiscal 2027. He emphasized Security momentum, especially recurring service revenue, RF wins, and long-term opportunities tied to government programs and large events like LA28. His tone was confident but measured, with repeated comments that the company remains focused on disciplined execution, backlog conversion, and margin expansion.
Alan Edrick highlighted that Q1 results benefited from record revenue and EPS, but also noted EPS growth was helped by lower net interest expense and a lower share count. He said gross margin was pressured by lower Healthcare sales, the mix of low-margin Opto revenue, and less favorable Security mix, while SG&A was $69 million or 17.0% of sales and R&D was $19.4 million or 4.8% of revenue. He pointed to strong cash generation, with $37 million of operating cash flow, $7.7 million of CapEx, $236 million of cash and cash equivalents, $66 million of short-term investments, and total debt of about $1.0 billion; the company also repurchased about 306,000 shares for about $62 million. He said the EPS guide increase mainly reflects the benefit of Q1 buybacks, while revenue guidance stayed the same because of geopolitical uncertainty.
Analysts focused on why revenue guidance was unchanged despite record backlog; management said there is upside, but given Middle East uncertainty they preferred to stay conservative, and the backlog also improves visibility into fiscal 2028 and beyond. Questions about services growth were answered with a detailed explanation that service revenue should accelerate meaningfully in Q2 through the balance of the year, driven by warranty roll-offs, aviation service, SaaS, and RF. On Middle East escalation risk and U.S. funding for RF-related programs, management said they have built in what they can, feel good about near-term programs, and believe much of the relevant funding is already in place. Analysts also asked about capital allocation and RF capacity; management said organic investment remains the top priority, M&A must be strategic, repurchases remain opportunistic, and current RF facilities plus the option for a second shift appear sufficient for now.
The call showed clear demand momentum: record backlog, a 1.4 book-to-bill, and strong bookings across Security, Opto, and RF. Management also said service revenue should accelerate through the year and help margins, while free cash flow is expected to exceed net income and backlog supports visibility into fiscal 2028 and beyond.
Margins were down year over year, with gross margin falling to 30.7% and adjusted operating margin to 9.5%, due to Healthcare weakness and product mix. Revenue guidance was not raised despite record backlog because management still sees geopolitical and funding uncertainty, including the Middle East, Mexico program timing, and U.S. government procurement timing. Healthcare also remains soft, with revenue down 14% and hospital capital spending still cautious.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 94.4%
- Shares Outstanding
- 15.73M
- Float Shares
- 14.84M
of shares held by institutions
378 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Blackrock, Inc. | 2.56M | ▲ 11.29K |
| Vanguard Group Inc | 2.11M | ▼ 981 |
| Vanguard Portfolio Management LLC | 1.25M | ▼ 20.13K |
| Fmr LLC | 1.11M | ▼ 631.08K |
| Jupiter Topco LLC | 905.92K | ▲ 905.92K |
| Janus Henderson Group Ltd. | 901.28K | ▲ 901.28K |
| Capital International Investors | 710.53K | ▲ 114.20K |
| Vanguard Capital Management LLC | 676.70K | ▼ 26.37K |
| State Street Corp | 675.17K | ▲ 1.12K |
| Ubs Am, A Distinct Business Unit Of Ubs Asset Management Americas LLC | 508.93K | ▲ 56.38K |
| Dimensional Fund Advisors LP | 440.28K | ▲ 26.25K |
| Geode Capital Management, LLC | 422.73K | ▼ 41.06K |
Held by 452 ETFs
Biggest fund positions in OSIS by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 9, 26 | Morben Paul Keith | sell | 536 |
| Aug 24, 26 | Tropeano Michael | other | 287 |
| Aug 24, 26 | Tropeano Michael | other | 99 |
| Aug 24, 26 | SZE VICTOR S | other | 16,845 |
| Aug 24, 26 | SZE VICTOR S | other | 14,999 |
| Aug 24, 26 | Okawa Cary M. | other | 908 |
| Aug 24, 26 | Okawa Cary M. | other | 460 |
| Aug 24, 26 | Morben Paul Keith | other | 1,083 |
| Aug 24, 26 | Morben Paul Keith | other | 1,331 |
| Aug 24, 26 | MEHRA AJAY | other | 20,073 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our OSIS coverage
Recent articles, reports, and earnings notes.
No research on OSIS yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate OSIS report →OSI Systems Receives $11 Million Order for Electronic Sub-Assemblies
businesswire.com · Nov 18
Why OSI Systems (OSIS) is a Top Growth Stock for the Long-Term
zacks.com · Nov 16
Why OSI Systems (OSIS) is a Top Value Stock for the Long-Term
zacks.com · Nov 13
OSI (OSIS) Upgraded to Buy: Here's Why
zacks.com · Nov 4
Wall Street Analysts Believe OSI (OSIS) Could Rally 31.62%: Here's is How to Trade
zacks.com · Nov 4
Why OSI Systems (OSIS) is a Top Momentum Stock for the Long-Term
zacks.com · Nov 3
OSI Systems, Inc. (OSIS) Q1 2027 Earnings Call Transcript
seekingalpha.com · Oct 30
OSI Systems (OSIS) Tops Q1 Earnings and Revenue Estimates
zacks.com · Oct 29
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.